Results 211 to 220 of about 121,506 (296)
We screened for gene candidates in the hippocampus related to anxiety using Hatano high avoidance animals (HAA) and low avoidance animals (LAA), inbred rat strains that exhibit high and low levels of anxiety‐like behavior. The microarray analysis revealed differences in 498 gene expressions between HAA and LAA, of which nine genes conducted RT‐qPCR ...
Kaito Sato+11 more
wiley +1 more source
Analysis of risk factors affecting prognosis of fulminant myocarditis in children: a ten-year single-center study. [PDF]
Yuan J+6 more
europepmc +1 more source
High-throughput untargeted metabolomic profiling of urinary biomarkers in acute myocarditis patients: a cross-sectional study. [PDF]
Zhao CM+5 more
europepmc +1 more source
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
J. Moslehi+4 more
semanticscholar +1 more source
A CASE OF MYOCARDITIS CAUSED BY MYCOPLASMA PNEUMONIAE
Yoko Yamane, Chuichi Kawai
openalex +2 more sources
ABSTRACT Background Metformin shows potential in combating clozapine‐induced weight gain (CIWG). However, current evidence for its use remains limited. Through an audit we determined the prevalence of metformin use among clozapine‐treated patients and its impact on weight and waist circumference (WC).
Bee Leng Per+5 more
wiley +1 more source
A case report of severe myocarditis combined with erythema multiforme caused by herpes simplex virus-1. [PDF]
Huang A, Lin B, Ji X, Chen S.
europepmc +1 more source
ABSTRACT Background The impact of baseline cardiovascular disease (CVD) on survival in patients undergoing immune checkpoint inhibitor (ICI) therapy is not well understood. Therefore, we sought to determine the relationship between baseline CVD on mortality in patients undergoing ICI monotherapy or combination therapy.
Aditya Mahadevan+5 more
wiley +1 more source
Myocarditis prediction in locally advanced or metastatic lung cancer patients with cardiac parameters abnormalities undergoing immunotherapy: development and validation of a risk assessment model. [PDF]
Li S+5 more
europepmc +1 more source